Cyclosporine in Severe Psoriasis
- 1 January 2001
- journal article
- Published by Springer Nature in American Journal of Clinical Dermatology
- Vol. 2 (1) , 41-47
- https://doi.org/10.2165/00128071-200102010-00007
Abstract
A meta-analysis of 3 major German studies conducted between 1989 and 1994 with cyclosporine in severe psoriasis was performed to allow an integrated evaluation of the efficacy and tolerability of cyclosporine in this indication.Keywords
This publication has 23 references indexed in Scilit:
- Consensus Conference on cyclosporin A for psoriasis February 1992British Journal of Dermatology, 2008
- Effects of cyclosporine on cytokines and cytokine receptors in psoriasisJournal of the American Academy of Dermatology, 1995
- Long-term maintenance therapy with cyclosporine and posttreatment survey in severe psoriasis: Results of a multicenter studyJournal of the American Academy of Dermatology, 1995
- Low-dose short-term cyclosporine versus etretinate in psoriasis: Improvement of skin, nail, and joint involvementJournal of the American Academy of Dermatology, 1995
- Cyclosporin A Rapidly Inhibits Epidermal Cytokine Expression in Psoriasis Lesions, But Not in Cytokine-Simulated Cultured KeratinocytesJournal of Investigative Dermatology, 1993
- Changes in numbers of epidermal cell adhesion molecules caused by oral cyclosporin in psoriasis.Journal of Clinical Pathology, 1993
- Cyclosporin a in the treatment of chronic plaque psoriasis: Six years experienceJournal of Dermatological Treatment, 1993
- Studies of the Effect of Cyclosporine in Psoriasis In Vivo: Combined Effects on Activated T Lymphocytes and Epidermal Regenerative MaturationJournal of Investigative Dermatology, 1992
- Adhesion molecule expression in psoriatic skin lesions and the influence of cyclosporin AClinical and Experimental Immunology, 1991
- Cyclosporin A Suppresses ICAM-1 Expression by Papillary Endothelium in Healing Psoriatic PlaquesJournal of Investigative Dermatology, 1991